SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will participate in the following investor conferences:
Read more at globenewswire.comSkye Bioscience Announces Participation in February Conferences
SKYE BIOSCIENCE INC
NASDAQ:SKYE (2/11/2025, 8:00:01 PM)
After market: 2.98 +0.09 (+3.11%)2.89
-0.54 (-15.74%)
SKYE Latest News and Analysis
12 hours ago - ChartmillTuesday's session: top gainers and losersIntrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
